Literature DB >> 10189857

Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure.

P Javlé1, J Yates, H G Kynaston, K F Parsons, S A Jenkins.   

Abstract

BACKGROUND: Massive liver necrosis, characteristic of acute liver failure, may affect hepatosplanchnic haemodynamics, and contribute to the alterations in renal haemodynamics and function. AIMS: To investigate the relation between hepatosplanchnic haemodynamics, including portal systemic shunting, and renal blood flow and function in rats with acute liver failure.
METHODS: Liver failure was induced in male Wistar rats by intraperitoneal injection of 1.1 g/kg of D(+)-galactosamine hydrochloride. The parameters assessed included; systemic, hepatosplanchnic, and renal blood flow (57Co microsphere method); portal-systemic shunting and intrarenal shunting (consecutive intrasplenic, intraportal, or renal arterial injections of 99mTc methylene diphosphonate and 99mTc albumin microspheres); arterial blood pressure and portal pressure; renal function; and liver function (liver function tests and 14C aminopyrine breath test).
RESULTS: Progressive liver dysfunction was accompanied by the development of a hyperdynamic circulation, a highly significant decrease in renal blood flow and function, and an increase in intrarenal shunting 36, 42, and 48 hours after administration of D-galactosamine. The alterations in renal blood flow and function were accompanied by significant increases in portal pressure, portal venous inflow, and intrahepatic portal systemic shunting in galactosamine treated rats compared with controls. There was a significant correlation between changes in renal blood flow and changes in portal pressure, intrahepatic portal systemic shunting, and deterioration in liver function (r = 0.8, p < 0.0001).
CONCLUSIONS: The results of this study suggest that both increased intrahepatic portal systemic shunting and hepatocyte impairment may contribute to alterations in renal haemodynamics and function.

Entities:  

Mesh:

Year:  1998        PMID: 10189857      PMCID: PMC1727229          DOI: 10.1136/gut.43.2.272

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

Review 1.  Hepatorenal syndrome.

Authors:  J R Schelling; S L Linas
Journal:  Semin Nephrol       Date:  1990-11       Impact factor: 5.299

2.  Effect of portal-systemic anastomosis on renal haemodynamics in cirrhosis.

Authors:  H Ring-Larsen; B Hesse; B Stigsby
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

Review 3.  Vasodilatation associated with hepatocellular disease: relation to functional organ failure.

Authors:  S Sherlock
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

4.  Renal and systemic hemodynamics in experimental cirrhosis in rats: relation to hepatic function.

Authors:  G Wensing; R Sabra; R A Branch
Journal:  Hepatology       Date:  1990-07       Impact factor: 17.425

5.  Preservation of glucuronidation in carbon tetrachloride-induced acute liver injury in the rat.

Authors:  P V Desmond; R James; S Schenker; J F Gerkens; R A Branch
Journal:  Biochem Pharmacol       Date:  1981-05-01       Impact factor: 5.858

6.  Renal function in fulminant hepatic failure: haemodynamics and renal prostaglandins.

Authors:  F Guarner; R D Hughes; A E Gimson; R Williams
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

7.  Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study.

Authors:  J Reichen; B Arts; U Schafroth; A Zimmermann; B Zeltner; T Zysset
Journal:  Gastroenterology       Date:  1987-10       Impact factor: 22.682

8.  Phenobarbital influences the development of sodium retention in liver disease induced by bile duct ligation in the rat.

Authors:  G Wensing; R A Branch
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

9.  The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function.

Authors:  G Wensing; R Sabra; R A Branch
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

10.  Biochemical, hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment.

Authors:  E Chirito; C Lister; T M Chang
Journal:  Artif Organs       Date:  1979-02       Impact factor: 3.094

View more
  9 in total

1.  Hepatoprotective effect of nitric oxide in experimental model of acute hepatic failure.

Authors:  Marek Saracyn; Marek Brytan; Robert Zdanowski; Tomasz Ząbkowski; Przemysław Dyrla; Janusz Patera; Stanisław Wojtuń; Wojciech Kozłowski; Zofia Wańkowicz
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

2.  TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury.

Authors:  J Muntané; F J Rodríguez; O Segado; A Quintero; J M Lozano; E Siendones; C A Pedraza; M Delgado; F O'Valle; R García; J L Montero; M De La Mata; G Miño
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

3.  Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure.

Authors:  R Anand; D Harry; S Holt; P Milner; M Dashwood; D Goodier; M Jarmulowicz; K Moore
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

4.  Hemodynamic studies in acute-on-chronic liver failure.

Authors:  Ashish Kumar; Kunal Das; Praveen Sharma; Vimal Mehta; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  Dig Dis Sci       Date:  2008-08-09       Impact factor: 3.199

5.  Protective effects of ellagic acid in D-galactosamine-induced kidney damage in rats.

Authors:  Adnan Ayhanci; Mustafa Cengiz; H Mehtap Kutlu; Djanan Vejselova
Journal:  Cytotechnology       Date:  2015-12-12       Impact factor: 2.058

6.  D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure?

Authors:  Marek Saracyn; Robert Zdanowski; Marek Brytan; Grzegorz Kade; Zbigniew Nowak; Janusz Patera; Przemysław Dyrla; Jerzy Gil; Zofia Wańkowicz
Journal:  Med Sci Monit       Date:  2015-05-22

7.  Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats.

Authors:  Ahmed Atwa; Rehab Hegazy; Rania Mohsen; Neamat Yassin; Sanaa Kenawy
Journal:  Open Access Maced J Med Sci       Date:  2017-12-13

8.  Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome.

Authors:  Marek Saracyn; Janusz Patera; Janusz Kocik; Marek Brytan; Robert Zdanowski; Arkadiusz Lubas; Wojciech Kozłowski; Zofia Wańkowicz
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

9.  Amelioration of galactosamine-induced nephrotoxicity by a protein isolated from the leaves of the herb, Cajanus indicus L.

Authors:  Mahua Sinha; Prasenjit Manna; Parames C Sil
Journal:  BMC Complement Altern Med       Date:  2007-04-25       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.